The effect of calorie restriction and exercise training with or without foot reflexology on body composition and cardiovascular diseases risk factors

Comparison of the effect of calorie restriction and exercise training with or without foot reflexology on body composition and cardiovascular diseases risk factors in obese females

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240517061818N1

Enrollment

Registered

2024-05-25

Start date

2024-05-20

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group 1: This intervention group will receive caloric restriction + resistance and aerobic exercise + foot reflexology. At first, a three-day food diary will be taken fro

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: age 20-50 years desire to participate in research with normal foot soles and without foot abnormalities (calluses, scars, neuropathy) no mental health issues (depression or anxiety) or taking neuropsychiatric drugs no perception disorders no history of foot reflexology no history of chronic pain such as arthritis without history of medical problems without having a special diet (diabetic, low-salt and low-fat, etc.) no taking special medicine or supplement.

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
Body composition. Timepoint: Body composition will be evaluated before (T0), at the end of the seventh (T7) and fourteenth (T14) weeks of the intervention. Method of measurement: Assessment of body composition (body fat, BF, %, lean mass - KG FFM, %, muscle mass MM) with an electric bioimpedance (BIA) device (Tanita Body Composition Analyzer BC-418), Olympia model 3/3, Jawon Co., South Korea will be measured.;Cardiovascular diseases risk factors. Timepoint: Cardiovascular risk factor will be evaluated before (T0), at the end of the seventh (T7) and fourteenth (T14) weeks of the intervention. Method of measurement: The levels of the following blood metabolic variables were examined in all study participants: glucose (GL), total cholesterol (TCh), HDL, LDL and triglyceride (TG). Smoking, drinking or vigorous exercise were prohibited. The blood sample was taken from 8 to 9 am in the fasting state, and 5 ml each time from the brachial vein of the person in a sitting position. Then it was poured inside the test tube containing a saturated solution of ethylene diamine tetra acetic acid (EDTA) made by Pars Azmoun. To separate the plasma, the blood was centrifuged for 15 minutes at a speed of 3500 rpm by a Hettich centrifuge from Germany. The plasma was frozen at a temperature of minus 80 degrees Celsius in a Mihan Azma freezer made in Iran. Enzymatic method will be used to measure the plasma levels of glucose, TG, cholesterol, LDL and HDL using the kits of Pars Azmoun company using the automatic biochemistry analyzer (Flexor / Selectra EL 200) made by Lab-Plus International, Germany.	—

Measure

Time frame

Body composition. Timepoint: Body composition will be evaluated before (T0), at the end of the seventh (T7) and fourteenth (T14) weeks of the intervention. Method of measurement: Assessment of body composition (body fat, BF, %, lean mass - KG FFM, %, muscle mass MM) with an electric bioimpedance (BIA) device (Tanita Body Composition Analyzer BC-418), Olympia model 3/3, Jawon Co., South Korea will be measured.;Cardiovascular diseases risk factors. Timepoint: Cardiovascular risk factor will be evaluated before (T0), at the end of the seventh (T7) and fourteenth (T14) weeks of the intervention. Method of measurement: The levels of the following blood metabolic variables were examined in all study participants: glucose (GL), total cholesterol (TCh), HDL, LDL and triglyceride (TG). Smoking, drinking or vigorous exercise were prohibited. The blood sample was taken from 8 to 9 am in the fasting state, and 5 ml each time from the brachial vein of the person in a sitting position. Then it was poured inside the test tube containing a saturated solution of ethylene diamine tetra acetic acid (EDTA) made by Pars Azmoun. To separate the plasma, the blood was centrifuged for 15 minutes at a speed of 3500 rpm by a Hettich centrifuge from Germany. The plasma was frozen at a temperature of minus 80 degrees Celsius in a Mihan Azma freezer made in Iran. Enzymatic method will be used to measure the plasma levels of glucose, TG, cholesterol, LDL and HDL using the kits of Pars Azmoun company using the automatic biochemistry analyzer (Flexor / Selectra EL 200) made by Lab-Plus International, Germany.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeyla Esmealy

university of Tabriz

leylaesmealy@gmail.com+98 41 3637 8742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026